Epithelial NAD(+) depletion drives mitochondrial dysfunction and contributes to intestinal inflammation
Targets thin skin, visible veins, pigmentation, fine lines, and volume loss while improving skin thickness, tone, hydration, and youthful fullness
Some researchers and clinicians advocate for the higher end of this range, up to 2.4 grams per kilogram, when fasting is combined with caloric restriction and GLP-1 therapy
In overweight individuals, tirzepatide specifically has been shown to reduce diabetes risk by over 90 percent
Increasing insulin release Lowering the amount of glucagon released Delaying gastric emptying Reducing appetite Can GLP1 medications be used for diabetes and weight loss together